KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BeOne Medicines (ONC) Asset Utilization Ratio (2016 - 2025)

BeOne Medicines (ONC) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.53 as the latest value for Q1 2024.

  • On a quarterly basis, Asset Utilization Ratio rose 82.22% to 0.53 in Q1 2024 year-over-year; TTM through Mar 2024 was 0.53, a 82.22% increase, with the full-year FY2024 number at 0.71, up 48.62% from a year prior.
  • Asset Utilization Ratio was 0.53 for Q1 2024 at BeOne Medicines, up from 0.49 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.53 in Q1 2024 to a low of 0.04 in Q2 2020.
  • A 5-year average of 0.21 and a median of 0.2 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 153.95% in 2020, then soared 713.5% in 2021.
  • BeOne Medicines' Asset Utilization Ratio stood at 0.06 in 2020, then skyrocketed by 207.68% to 0.17 in 2021, then skyrocketed by 36.29% to 0.23 in 2022, then soared by 109.83% to 0.49 in 2023, then rose by 8.27% to 0.53 in 2024.
  • Per Business Quant, the three most recent readings for ONC's Asset Utilization Ratio are 0.53 (Q1 2024), 0.49 (Q4 2023), and 0.4 (Q3 2023).